SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
Sabrina Lusvarghi(Center for Biologics Evaluation and Research), Carol D. Weiss(Center for Biologics Evaluation and Research), Ann E. Eakin(National Institutes of Health), Monique Hollis-Perry(Naval Medical Research Command), Christopher C. Broder(Uniformed Services University of the Health Sciences), Timothy Burgess(Uniformed Services University of the Health Sciences), Nusrat J Epsi(Henry M. Jackson Foundation), Evan Ewers(Alexander T. Augusta Military Medical Center), Eric D. Laing(Uniformed Services University of the Health Sciences), Anthony C Fries(Wright-Patterson Air Force Base), Tahaniyat Lalani(Henry M. Jackson Foundation), Lisa Bentley(Office of Readiness and Response), Karl J. Erlandson(Biomedical Advanced Research and Development Authority), Rupal Mody(William Beaumont Army Medical Center), Richard Wang(Center for Biologics Evaluation and Research), Wei Wang(Center for Biologics Evaluation and Research), Leah C. Katzelnick(National Institutes of Health), Si’Ana A. Coggins(Henry M. Jackson Foundation), Edward Mitre(Uniformed Services University of the Health Sciences), Gregory Wang(Naval Medical Research Command), Mark P. Simons(Uniformed Services University of the Health Sciences), Sabari Nath Neerukonda(Center for Biologics Evaluation and Research), David A Lindholm(Uniformed Services University of the Health Sciences), Russell Vassell(Center for Biologics Evaluation and Research), David R. Tribble(Naval Medical Research Command), Christopher Colombo(Madigan Army Medical Center), Simon Pollett(Henry M. Jackson Foundation), Brian K. Agan(Henry M. Jackson Foundation), Anuradha Ganesan(Walter Reed National Military Medical Center), Emilie Goguet(Henry M. Jackson Foundation)
Cited by 94
Related Papers
Antibody landscapes after influenza virus infection or vaccination
|Science|2014|514
A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
|PLoS Pathogens|2009|333
Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report
|Journal of Travel Medicine|2017|265
Dengue
|The Lancet|2024|264
IMPACT OF ILLNESS AND NON-COMBAT INJURY DURING OPERATIONS IRAQI FREEDOM AND ENDURING FREEDOM (AFGHANISTAN)
|American Journal of Tropical Medicine and Hygiene|2005|237